$336 Million is the total value of MPM ASSET MANAGEMENT LLC's 6 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPTX | New | Repare Therapeutics, Inc. | $93,177,000 | – | 3,003,772 | +100.0% | 27.72% | – |
| HARP | Harpoon Therapeutics, Inc. | $75,105,000 | +43.3% | 4,524,425 | 0.0% | 22.35% | -29.9% | |
| TCRR | TCR2 Therapeutics, Inc. | $62,221,000 | +98.4% | 4,050,865 | 0.0% | 18.51% | -2.9% | |
| RYTM | Sell | Rhythm Pharmaceuticals, Inc. | $42,576,000 | +18.6% | 1,909,258 | -19.1% | 12.67% | -42.0% |
| SNDX | Syndax Pharmaceuticals, Inc. | $32,140,000 | +35.1% | 2,168,691 | 0.0% | 9.56% | -33.9% | |
| CHMA | Chiasma, Inc. | $30,861,000 | +47.4% | 5,736,296 | 0.0% | 9.18% | -27.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Chiasma, Inc. | 24 | Q2 2021 | 19.8% |
| Aratana Therapeutics, Inc. | 24 | Q1 2019 | 26.8% |
| Conatus Pharmaceuticals, Inc. | 23 | Q1 2019 | 9.7% |
| Rhythm Pharmaceuticals, Inc. | 19 | Q2 2022 | 69.9% |
| Harpoon Therapeutics, Inc. | 19 | Q3 2023 | 31.9% |
| Syndax Pharmaceuticals, Inc. | 19 | Q3 2020 | 14.5% |
| Radius Health, Inc. | 17 | Q2 2018 | 76.4% |
| TCR2 Therapeutics, Inc. | 17 | Q1 2023 | 29.1% |
| Proteon Therapeutics, Inc. | 17 | Q4 2018 | 3.0% |
| EpiZyme, Inc. | 15 | Q4 2016 | 35.9% |
View MPM ASSET MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-09-07 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-05 |
| 4 | 2023-05-24 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
View MPM ASSET MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.